BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 36077101)

  • 1. Targeted Mitochondrial Epigenetics: A New Direction in Alzheimer's Disease Treatment.
    Song Y; Zhu XY; Zhang XM; Xiong H
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's Disease-Related Epigenetic Changes: Novel Therapeutic Targets.
    Paniri A; Hosseini MM; Akhavan-Niaki H
    Mol Neurobiol; 2024 Mar; 61(3):1282-1317. PubMed ID: 37700216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics in Alzheimer's Disease: Perspective of DNA Methylation.
    Qazi TJ; Quan Z; Mir A; Qing H
    Mol Neurobiol; 2018 Feb; 55(2):1026-1044. PubMed ID: 28092081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial DNA: Epigenetics and environment.
    Sharma N; Pasala MS; Prakash A
    Environ Mol Mutagen; 2019 Oct; 60(8):668-682. PubMed ID: 31335990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics of Alzheimer's Disease.
    Nikolac Perkovic M; Videtic Paska A; Konjevod M; Kouter K; Svob Strac D; Nedic Erjavec G; Pivac N
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From powerhouse to regulator: The role of mitoepigenetics in mitochondrion-related cellular functions and human diseases.
    Donato L; Mordà D; Scimone C; Alibrandi S; D'Angelo R; Sidoti A
    Free Radic Biol Med; 2024 Jun; 218():105-119. PubMed ID: 38565400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease.
    Yu CC; Jiang T; Yang AF; Du YJ; Wu M; Kong LH
    Neural Plast; 2019; 2019():6856327. PubMed ID: 31093272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulons in Alzheimer's disease.
    Raval M; Mishra S; Tiwari AK
    Prog Mol Biol Transl Sci; 2023; 198():185-247. PubMed ID: 37225321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation in Alzheimer's disease: is it a potential therapeutic target?
    Coppedè F
    Expert Opin Ther Targets; 2021 Apr; 25(4):283-298. PubMed ID: 33843425
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of mitochondrial gene expression, the epigenetic enigma.
    Mposhi A; Van der Wijst MG; Faber KN; Rots MG
    Front Biosci (Landmark Ed); 2017 Mar; 22(7):1099-1113. PubMed ID: 28199194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered mitochondrial DNA methylation and mitochondrial DNA copy number in an APP/PS1 transgenic mouse model of Alzheimer disease.
    Xu Y; Xu L; Han M; Liu X; Li F; Zhou X; Wang Y; Bi J
    Biochem Biophys Res Commun; 2019 Nov; 520(1):41-46. PubMed ID: 31564416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of mitochondrial function in neurodegenerative disease: New insights from advances in genomic technologies.
    Devall M; Roubroeks J; Mill J; Weedon M; Lunnon K
    Neurosci Lett; 2016 Jun; 625():47-55. PubMed ID: 26876477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Epigenetic Targets for Combating Alzheimer's Disease.
    Pandey D; Pal T; Sharma A; Flora S
    Mini Rev Med Chem; 2021; 21(12):1527-1540. PubMed ID: 33371834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Regulation of Amyloid-beta Metabolism in Alzheimer's Disease.
    He C; Huang ZS; Yu CC; Wang HH; Zhou H; Kong LH
    Curr Med Sci; 2020 Dec; 40(6):1022-1030. PubMed ID: 33428129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic drugs in Alzheimer's disease.
    Cuadrado-Tejedor M; Oyarzabal J; Lucas MP; Franco R; García-Osta A
    Biomol Concepts; 2013 Oct; 4(5):433-45. PubMed ID: 25436752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of epigenetics in Alzheimer's disease pathogenesis.
    Stoccoro A; Coppedè F
    Neurodegener Dis Manag; 2018 Jun; 8(3):181-193. PubMed ID: 29888987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased Methylation of the Mitochondrial D-Loop Region in Late-Onset Alzheimer's Disease.
    Stoccoro A; Siciliano G; Migliore L; Coppedè F
    J Alzheimers Dis; 2017; 59(2):559-564. PubMed ID: 28655136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
    Nagu P; Parashar A; Behl T; Mehta V
    J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics in Alzheimer's disease: a focus on DNA modifications.
    Coppieters N; Dragunow M
    Curr Pharm Des; 2011; 17(31):3398-412. PubMed ID: 21902668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetics in Alzheimer's Disease: A Critical Overview.
    Villa C; Combi R
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.